A new approach to the treatment of metastatic paraganglioma: sorafenib.

MLA

Gunaldi, Meral, et al. “A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib.” Cancer Research and Treatment, vol. 46, no. 4, Oct. 2014, pp. 411–14. EBSCOhost, https://doi.org/10.4143/crt.2013.093.

APA

Gunaldi, M., Kara, I. O., Duman, B. B., Afsar, C. U., Ergin, M., & Avci, A. (2014). A new approach to the treatment of metastatic paraganglioma: sorafenib. Cancer Research and Treatment, 46(4), 411–414. https://doi.org/10.4143/crt.2013.093

Chicago

Gunaldi, Meral, Ismail Oguz Kara, Berna Bozkurt Duman, Cigdem Usul Afsar, Melek Ergin, and Arbil Avci. 2014. “A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib.” Cancer Research and Treatment 46 (4): 411–14. doi:10.4143/crt.2013.093.